Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02945228
Other study ID # P15-764
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 26, 2016
Est. completion date July 26, 2019

Study information

Verified date June 2020
Source AbbVie
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main objective of this study is to evaluate the safety and effectiveness of paritaprevir/ritonavir/ombitasvir with ribavirin used for participants infected with chronic hepatitis C virus (HCV) genotype 2 in daily practice in Japan.


Recruitment information / eligibility

Status Completed
Enrollment 449
Est. completion date July 26, 2019
Est. primary completion date July 26, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- HCV genotype 2 participants treated with paritaprevir/ritonavir/ombitasvir plus ribavirin in daily practice.

Exclusion Criteria:

- Participants who have been previously treated with paritaprevir/ritonavir/ombitasvir and ribavirin.

Study Design


Locations

Country Name City State
Japan Kato Michio Hepatology Clinic /ID# 159476 Amagasaki, Hyogo
Japan Aomori Prefectural Central Hos /ID# 160822 Aomori-shi
Japan Mantani Clinic /ID# 168353 Arida
Japan Japanese Red Cross Asahikawa /ID# 165265 Asahikawa
Japan Asahikawa City Hospital /ID# 167703 Asahikawa-shi
Japan Chiba University Hospital /ID# 160875 Chiba
Japan National Hospital Organization /ID# 168346 Chiba
Japan Seirei Sakura Citizen Hospital /ID# 166896 Chiba
Japan Kenseido-iin /ID# 164166 Chichibu
Japan University of Yamanashi Hospital /ID# 161770 Chuo-shi Yamanashi
Japan Fuji City General Hospital /ID# 165278 Fuji
Japan Kusunoki Hospital /ID# 158119 Fujioka Gunma
Japan Fukui Prefectural Hospital /ID# 168344 Fukui
Japan Fukui Prefectural Hospital /ID# 169552 Fukui
Japan University of Fukui Hospital /ID# 166933 Fukui
Japan Chihaya Hospital /ID# 161893 Fukuoka
Japan NHO Kyushu Medical Center /ID# 162956 Fukuoka-shi Fukuoka
Japan Morichika Internal Medicine /ID# 168351 Fukuyama
Japan Fukuyama City Hospital /ID# 161889 Fukuyama-shi Hiroshima
Japan NHO Fukuyama Medical Center /ID# 162909 Fukuyama-shi Hiroshima
Japan Gifu Municipal Hospital /ID# 165287 Gifu
Japan Shiroyama Hospital /ID# 164963 Habikino-osaka
Japan Aomori Rosai Hospital /ID# 167702 Hachinohe
Japan Hamamatsu University Hospital /ID# 171048 Hamamatsu Shizuoka
Japan Tamakoshi Clinic /ID# 165282 Hamamatsu
Japan Higashihiroshima Medical Ctr /ID# 168343 Higashihiroshima
Japan Mito Medical Center /ID# 171046 Higashiibaraki-gun
Japan Higashiomicity Notogawa Hosp /ID# 161891 Higashiomi, Shiga
Japan Shin-ishikiri Clinic /ID# 169643 Higashiosaka
Japan Wakakusa Daiichi Hospital /ID# 166882 Higashiosaka
Japan Hiroshima Red Cross Hosp Atomi /ID# 162912 Hiroshima
Japan Hiroshima University Hospital /ID# 160815 Hiroshima
Japan Hiroshima-Nishi Medical Center /ID# 169642 Hiroshima
Japan Koyo New Town Hospital /ID# 161890 Hiroshima
Japan Taishi Hospital /ID# 165291 Hyogo
Japan Iizuka Hospital /ID# 161886 Iizuka
Japan Ikeda Municipal Hospital /ID# 160814 Ikeda
Japan Tokyo Med Uni Ibaraki Med Ctr /ID# 162955 Inashiki
Japan Nippon Med Chiba Hokusoh Hosp /ID# 162902 Inzai
Japan Saitama Medical University Hos /ID# 161768 Iruma-gun
Japan Itoigawa Sogo Hospital /ID# 166884 Itoigawa
Japan Kamiiwade Internal Med-Neuro /ID# 166881 Iwade
Japan Nanpuh Hospital /ID# 168348 Kagoshima-shi Kagoshima
Japan Kaizuka City Hospital /ID# 165256 Kaizuka
Japan Kamisu Saiseikai Hospital /ID# 167701 Kamisu
Japan Hiratsuka City Hospital /ID# 161884 Kanagawa
Japan Kiyokawa Hospital /ID# 164961 Kanagawa
Japan Niwa Hospital /ID# 167684 Kanagawa
Japan Fuji Clinic /ID# 160820 Kanonji
Japan Ibaraki Prefectural Cent. Hosp /ID# 164962 Kasama
Japan The Jikei Univ. Kashiwa Hosp. /ID# 166888 Kashiwa-shi
Japan Kashiwazaki General Hospital a /ID# 168352 Kashiwazaki
Japan Kawase Clinic /ID# 164957 Kasugai
Japan Hirose Clinic /ID# 167699 Kawagoe
Japan Sekishindo Hospital /ID# 162960 Kawagoe
Japan Saitama Medical Center, Saitama Medical University /ID# 162911 Kawagoe-shi Saitama
Japan Kawaguchi Municipal Medical Ce /ID# 165270 Kawaguchi
Japan Kawasaki Municipal Tama Hospit /ID# 165267 Kawasaki
Japan St. Marianna University School of Medicine Hospital /ID# 160876 Kawasaki Kanagawa
Japan Kanto Rosai Hospital /ID# 165258 Kawasaki-shi, Kanagawa
Japan Kishiwada Tokushukai Hospital /ID# 164964 Kishiwada, Osaka
Japan Kokura Kinen Hospital /ID# 164969 Kitakyusyu
Japan Kitasato University Medical Ce /ID# 158120 Kitamoto
Japan Kobe Adventist Hospital /ID# 161897 Kobe
Japan Kobe Asahi Hospital /ID# 161896 Kobe
Japan Tokyo Jikei Daisan Hospital /ID# 164159 Komae-shi Tokyo
Japan Konan Kosei Hospital /ID# 165277 Konan-shi
Japan Cosmos Clinic /ID# 164161 Koriyama
Japan Ishida Medical Clinic /ID# 166887 Koriyama
Japan Dokkyo Medical University Saitama Medical Center /ID# 162907 Koshigaya Saitama
Japan Hanada Internal Medicine Clin /ID# 165266 Koshigaya, Saitam
Japan Kumamoto Shinto General Hospital /ID# 165275 Kumamoto-shi Kumamoto
Japan Kumamoto University Hospital /ID# 167048 Kumamoto-shi Kumamoto
Japan Kawasaki Medical School Hosp /ID# 162906 Kurashiki
Japan National Hosp Org Kure Med Cen /ID# 167689 Kure, Hiroshima
Japan Kurihara Central Hospital /ID# 171047 Kurihara
Japan Kuroishi Hospital /ID# 164971 Kuroishi-aomori
Japan Koga Hospital 21 /ID# 167698 Kurume
Japan Shin Koga Clinic /ID# 164972 Kurume
Japan Kurume University Hospital /ID# 164158 Kurume-shi Fukuoka
Japan Hori Internal Medicine Clinic /ID# 167696 Kushiro
Japan Matsuzaki Internal Medicine Cl /ID# 164970 Kyoto
Japan NHO Kyoto Medical Center /ID# 162910 Kyoto
Japan Gibo Hepatorogy Clinic /ID# 161766 Matsumoto
Japan Matsuyama Red Cross Hosp /ID# 162953 Matsuyama Ehime
Japan Kizawa Memorial Hospital /ID# 162957 Minokamo
Japan Sumiyoshi Clinic Hospital /ID# 164163 Mito
Japan South Miyagi Medical Center /ID# 164965 Miyagi
Japan National Hospital Organization /ID# 168345 Miyakonojo
Japan Miyazaki Medical Center Hospit /ID# 165279 Miyazaki
Japan University of Miyazaki Hosp /ID# 166880 Miyazaki-shi
Japan Matsushita Memorial Hospital /ID# 167693 Moriguchi-shi
Japan Aichi Medical University Hosp /ID# 161892 Nagakute Aichi
Japan Suzuki Clinic /ID# 165264 Nagareyama
Japan Aikawa Minnano-shinryojo /ID# 164168 Nagoya
Japan Meitetsu Hospital /ID# 165288 Nagoya
Japan Meijo Hospital /ID# 164966 Nagoya-aichi
Japan Nagoya Central Hospital /ID# 166879 Nagoya-shi
Japan Nara City Hospital /ID# 162959 Nara
Japan Tani Internal Medicine Clinic /ID# 164974 Nayoro
Japan Ooka Clinic /ID# 161887 Nishinomiya
Japan The Hospital of Hyogo College of Medicine /ID# 162913 Nishinomiya-shi Hyogo
Japan Noshiro Yamamoto Med. Assoc. /ID# 162964 Noshiro
Japan Manna Clinic /ID# 169548 Odawara
Japan Oita Midical Center /ID# 164960 Oita
Japan Okayama Saiseikai Outpatient Center Hospital /ID# 159475 Okayama
Japan Okayama University Hospital /ID# 165268 Okayama-shi Okayama
Japan Omuta City Hospital /ID# 164967 Omuta
Japan Kita-harima Medical Center /ID# 164165 ONO
Japan Onomichi Central General Hospi /ID# 162903 Onomichi
Japan Asai Naika /ID# 167691 Osaka
Japan Asai Naika Iin /ID# 164955 Osaka
Japan Kenporen Osaka Central Hospita /ID# 164956 Osaka
Japan Osaka Hospital /ID# 164157 Osaka
Japan Osaka Inter. Cancer Institute /ID# 166889 Osaka
Japan Osaka Police Hospital /ID# 161769 Osaka
Japan Tamai Clinic /ID# 164162 Osaka
Japan Utajima Ueda Clinic /ID# 161894 Osaka
Japan Nippon Life Saiseikai Public Interest Foundation Nippon Life Hospital /ID# 167688 Osaka-shi Osaka
Japan Osaka City University Hospital /ID# 165290 Osaka-shi Osaka
Japan Osaka Red Cross Hospital /ID# 161888 Osaka-shi Osaka
Japan Seko Internal Medicine Clinic /ID# 164169 Otsu
Japan Kawazoe Internal Medicine Clin /ID# 165292 Saga
Japan Honda Internal Clinic /ID# 161767 Saitama
Japan Sainokuni Higashiomiya Medical /ID# 167700 Saitama
Japan Saitama Citizens Medical Ctr /ID# 169550 Saitama
Japan Saitama Cooperative Hospital /ID# 167697 Saitama
Japan Minamitani Clinic /ID# 160821 Sakai
Japan Kaisei Hospital /ID# 164973 Sapporo
Japan Sendai Kousei Hospital /ID# 162961 Sendai
Japan Tokyo Women's Medical University Hospital /ID# 167685 Shinjuku-ku Tokyo
Japan Saka General Hospital /ID# 162962 Shiogama-miyagi
Japan Saiseikai Suita Hospital /ID# 165289 Suita
Japan Suita Municipal Hospital /ID# 164958 Suita-osaka
Japan Kagawa Prefectural Central Hos /ID# 160816 Takamatsu
Japan Sawada Hepatology & Gastro /ID# 165255 Takaraduka
Japan National Hospital Organization Takasaki General Medical Center /ID# 160877 Takasaki-shi Gunma
Japan Tenjin Tanaka Internal Medicin /ID# 166883 Takatsuki
Japan Osaka Medical College Hospital /ID# 162908 Takatsuki -shi Osaka
Japan Hamada Clinic /ID# 171045 Tatebayashi
Japan Todachuo General Hospital /ID# 165280 Toda-shi, Saitama
Japan Eastern Chiba Medical Center /ID# 165257 Togane, Chiba
Japan Delta Clinic /ID# 164167 Tokorozawa
Japan Abbott Japan /ID# 144983 Tokyo
Japan JP Red Cross Musashino Hosp /ID# 162904 Tokyo
Japan Juntendo Univ Nerima Hosp /ID# 164160 Tokyo
Japan Juntendo University Hospital /ID# 161771 Tokyo
Japan Nippon Medical School Hospital /ID# 164164 Tokyo
Japan Ohashi Medical Office /ID# 164968 Tokyo
Japan The Jikei University Hospital /ID# 169547 Tokyo
Japan Tokyo Metropolitan Bokutoh Hos /ID# 167686 Tokyo
Japan Ehime University Hospital /ID# 161885 Toon
Japan Toyama University Hospital /ID# 169551 Toyoma
Japan Toyonaka Municipal Hospital /ID# 167692 Toyonaka
Japan Mie Syokaki Clinic /ID# 161895 Tsu, Mie
Japan Saiseikai Utsunomiya Hospital /ID# 162958 Utsunomiya
Japan Seike Clinic /ID# 166890 Uwajima
Japan Saiseikai Wakayama Hospital /ID# 162954 Wakayama
Japan Wakayama Rosai Hospital /ID# 165254 Wakayama-shi
Japan Tokyo Women's Medical Universi /ID# 167694 Yachiyo
Japan Tohoku Central Hospital /ID# 166897 Yamagata
Japan Okuda Gastrointestinal Medicin /ID# 168349 Yamaguchi
Japan Kainan Hospital /ID# 164959 Yatomi-shi
Japan Kumamoto Rosai Hospital /ID# 167695 Yatsushiro-shi
Japan Mie Prefectural General Medica /ID# 162963 Yokkaichi
Japan Yokohama City Univ Medical Ctr /ID# 162905 Yokohama Kanagawa
Japan Showa Univ Fujigaoka Hosp /ID# 162952 Yokohama-shi
Japan Oita University Hospital /ID# 169549 Yufu-shi
Japan Yamaguchi Surgery Clinic /ID# 167704 Yugawara
Japan Josai Hospital /ID# 168347 Yuki

Sponsors (1)

Lead Sponsor Collaborator
AbbVie

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Participants with Sustained Virologic Response (SVR12) Hepatitis C virus (HCV) ribonucleic acid (RNA) less than the lower limit of quantification (LLOQ) 12 weeks after the last dose of study drug. 12 weeks after last dose of study drug.
Secondary Percentage of Participants with Virologic Failure During Treatment (breakthrough) HCV RNA levels reach less than the LLOQ, then increase to greater than or equal to the LLOQ at any point during treatment. Up to 12 Weeks
Secondary Percentage of Participants with Virologic Failure After Treatment (relapse) Undetectable viremia (HCV RNA less than LLOQ) at the end of the 16 weeks treatment but subsequent viremia (HCV RNA greater than or equal to LLOQ) during the follow-up period of 24 weeks after treatment. Post-treatment 24 weeks
Secondary Percentage of Participants with Sustained Virologic Response (SVR24) HCV RNA less than the LLOQ 24 weeks after the last dose of study drug. 24 weeks after the last dose of study drug
See also
  Status Clinical Trial Phase
Withdrawn NCT02806362 - Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD) Phase 3
Completed NCT01701401 - Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV Phase 3
Withdrawn NCT01691235 - SIMpill Medication Dispensing Device in the Treatment of HCV N/A
Completed NCT01726517 - Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects Phase 2
Completed NCT01740791 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection Phase 1
Recruiting NCT05904470 - A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV Phase 2
Completed NCT01851330 - Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3) Phase 3
Completed NCT01852604 - Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005) Phase 2
Completed NCT02105467 - Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060) Phase 3
Recruiting NCT02038387 - Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD) N/A
Completed NCT01581138 - VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C Phase 2
Completed NCT02629172 - Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1
Completed NCT01768286 - Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection Phase 3
Completed NCT01686789 - Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 Phase 4
Completed NCT00610597 - Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease N/A
Completed NCT02707952 - A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection Phase 3
Completed NCT01516918 - A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis Phase 2
Completed NCT02723084 - A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection Phase 3

External Links